marilia
cascalho
jeffrey
l
platt
xenotransplant
refer
transplant
live
cell
tissu
organ
individu
speci
anoth
speci
among
variou
field
transplant
none
spark
greater
excit
none
greater
controversi
xenotransplant
chapter
consid
variou
applic
propos
xenotransplant
excit
deriv
chapter
address
hurdl
prevent
applic
xenotransplant
treatment
diseas
today
particularli
hurdl
stem
immun
respons
recipi
graft
hurdl
possibl
xenograft
might
serv
vehicl
transfer
infecti
organ
speci
controversi
deriv
although
variou
type
xenograft
contempl
even
tri
histori
xenotransplant
first
undertaken
earli
year
centuri
treatment
renal
failur
experiment
surgeon
recent
devis
vascular
anastomosi
way
connect
cut
end
blood
vessel
advanc
creat
field
vascular
surgeri
vascular
anastomosi
would
allow
repair
traumat
wound
penetr
surgeri
deeper
bodi
caviti
howev
develop
procedur
realiz
vascular
anastomosi
might
also
prove
critic
technic
advanc
need
replac
sick
organ
healthi
one
ie
organ
transplant
excit
prospect
organ
replac
seem
clear
one
could
obtain
organ
human
transplant
reason
sinc
cellular
compon
kidney
organ
often
remain
aliv
long
person
deceas
harvest
kidney
cadav
would
uneth
concern
first
applic
vascular
anastomosi
replac
organ
function
conduct
use
anim
swine
sheep
sourc
organ
instead
human
import
reason
interest
xenotransplant
today
provid
plenti
sourc
organ
lieu
human
organ
transplant
estim
number
human
organ
avail
transplant
equal
littl
number
need
case
kidney
liver
shortag
may
blunt
use
live
donor
howev
reason
discuss
demand
organ
transplant
may
soon
increas
dramat
today
organ
transplant
mainli
undertaken
treat
sever
failur
kidney
liver
heart
lung
advanc
public
health
medicin
allow
mani
live
advanc
age
preval
type
diabet
cardiovascular
diseas
increas
demand
transplant
demand
transplant
could
increas
advanc
molecular
diagnost
genom
proteom
make
possibl
detect
tumor
lethal
diseas
clinic
appar
diagnosi
diseas
spark
interest
use
transplant
preempt
condit
spare
patient
risk
wait
tumor
local
xenotransplant
may
even
prefer
circumst
humantohuman
transplant
viru
caus
organ
failur
xenotransplant
might
prefer
avoid
infect
transplant
organ
approach
alreadi
attempt
treatment
cirrhosi
caus
hepat
viru
loss
immun
compet
caus
human
immunodefici
viru
hiv
xenograft
least
xenogen
organ
might
use
temporari
measur
preserv
life
health
heal
occur
human
organ
becom
avail
thu
blood
subject
fulmin
hepat
failur
swine
liver
way
improv
subject
condit
patient
could
undergo
allotransplant
xenograft
might
use
deliv
gene
gene
product
complex
metabol
pathway
exploit
abil
express
heterolog
gene
high
level
genet
engin
anim
xenograft
humantoanim
even
advanc
system
might
coax
differenti
stem
cell
function
tissu
organ
unfortun
despit
mani
potenti
use
long
histori
interest
xenotransplant
daunt
biolog
barrier
present
prevent
widespread
applic
xenotransplant
barrier
includ
graft
injuri
caus
immun
respons
recipi
graft
physiolog
incompat
transplant
applic
xenotransplant
recipi
possibl
graft
might
transfer
infecti
organ
recipi
shall
consid
barrier
particularli
first
sourc
xenograft
ideal
xenograft
obtain
speci
genet
similar
recipi
genet
proxim
would
tend
minim
immunolog
barrier
transplant
might
improv
capac
graft
function
human
recipi
ideal
sourc
would
nonhuman
primat
tabl
list
outcom
experiment
trial
clinic
xenotransplant
renal
xenograft
chimpanze
function
month
human
subject
renal
failur
undoubtedli
far
better
result
could
achiev
today
despit
advantag
minim
genet
dispar
sourc
recipi
xenograft
nonhuman
primat
gener
view
use
sourc
clinic
xenograft
nonhuman
primat
suffici
numer
abund
small
size
provid
organ
tissu
need
clinic
xenotransplant
also
great
concern
nonhuman
primat
may
harbor
infecti
agent
particularli
virus
herp
b
simian
retrovirus
incomplet
character
potenti
lethal
human
instead
nonhuman
primat
speci
receiv
attent
potenti
sourc
clinic
xenograft
pig
pig
avail
larg
number
certainli
would
fulfil
conceiv
need
organ
tissu
pig
appropri
size
provid
function
organ
adult
born
litter
pig
genet
engin
bred
rel
eas
thu
transgen
knockout
pig
develop
xenotransplant
discuss
final
infecti
agent
potenti
carri
pig
well
character
except
endogen
retroviru
elimin
scrupul
breed
hous
program
immunolog
barrier
xenotransplant
might
expect
mani
facet
innat
elicit
immun
target
xenograft
thu
xenograft
engend
power
respons
complement
phagocyt
cell
natur
killer
nk
cell
antibodi
cell
intens
respons
thought
direct
function
phylogenet
distanc
sourc
graft
recipi
howev
mani
respons
xenotransplant
direct
function
genet
differ
inde
daunt
respons
particularli
antibodi
complement
power
exert
serum
tissu
constitu
anim
speci
rel
close
relat
section
follow
discuss
compon
innat
elicit
immun
recogn
injur
xenograft
follow
shall
consid
compon
actual
injur
graft
complement
pose
greatest
barrier
xenotransplant
least
organ
xenograft
activ
xenogen
organ
graft
complement
destroy
function
integr
graft
within
minut
hour
dramat
reaction
call
hyperacut
reject
use
year
test
complement
inhibitor
complement
human
mammal
activ
xenograft
altern
pathway
classic
pathway
chapter
altern
pathway
complement
regul
homolog
surfac
heterolog
surfac
factor
h
inhibit
associ
factor
b
activ
altern
pathway
complement
appear
provid
primari
barrier
xenotranspl
mani
combin
donor
recipi
speci
set
howev
exampl
transplant
porcin
organ
baboon
human
altern
pathway
complement
spontan
activ
presum
factor
h
function
across
speci
combin
sourc
recipi
speci
xenoreact
natur
antibodi
discuss
activ
complement
regardless
mechan
initi
activ
complement
kinet
extent
complement
activ
increas
due
lesser
abil
complement
regulatori
protein
control
heterolog
complement
condit
call
homolog
restrict
recent
studi
challeng
import
homolog
restrict
howev
observ
xenograft
transgen
anim
express
low
level
complement
regulatori
protein
recipi
avoid
sever
type
complementmedi
injuri
provid
compel
support
biolog
import
homolog
restrict
suggest
limit
xenotransplant
devis
effect
approach
prevent
control
activ
complement
seen
mani
year
key
success
applic
xenotransplant
experiment
model
agent
cobra
venom
factor
activ
altern
pathway
complement
solubl
complement
receptor
type
found
innat
respons
includ
xenoreact
natur
antibodi
complement
natur
killer
cell
adapt
immun
respons
includ
tcell
respons
peptid
deriv
mani
xenogen
protein
plu
major
histocompat
complex
adapt
humor
respons
includ
antibodi
mani
xenogen
antigen
biolog
outcom
xenograft
depend
type
graft
organ
xenograft
suscept
vascular
reject
cellular
reject
protect
accommod
tissu
cell
xenograft
suscept
mainli
cellular
reject
immunolog
barrier
xenotransplant
provid
suffici
protect
allow
surviv
organ
xenograft
period
day
week
despit
obviou
advantag
administ
complement
inhibitor
approach
sever
import
limit
first
action
complement
inhibitor
transient
wherea
complement
activ
persist
second
system
inhibit
complement
compromis
host
defens
infect
altern
standard
approach
control
activ
complement
express
complement
regulatori
protein
recipi
product
transgen
wouldb
sourc
xenograft
exampl
express
human
decayacceler
factor
membran
cofactor
protein
transgen
pig
led
prolong
surviv
organ
pig
transplant
nonhuman
primat
xenoreact
natur
antibodi
vertebr
capabl
produc
antibodi
least
natur
antibodi
antibodi
call
natur
antibodi
produc
without
known
histori
sensit
correspond
antigen
natur
antibodi
includ
polyreact
antibodi
bind
mani
differ
dispar
type
antigen
monoreact
natur
antibodi
mainli
recogn
one
saccharid
bestknown
monoreact
natur
antibodi
isohemagglutinin
recogn
blood
group
b
antigen
xenoreact
natur
antibodi
natur
antibodi
recogn
cell
foreign
speci
known
decad
xenoreact
antibodi
may
polyreact
monoreact
xenoreact
polyreact
antibodi
like
polyreact
antibodi
thought
made
b
cell
whether
xenoreact
polyreact
antibodi
activ
complement
exert
effector
function
caus
diseas
uncertain
hand
monoreact
xenoreact
antibodi
thought
contribut
import
barrier
xenotransplant
bestcharacter
xenoreact
antibodi
antibodi
specif
produc
action
transferas
grow
oligosaccharid
chain
function
transferas
produc
lower
mammal
new
world
monkey
human
ape
old
world
monkey
produc
function
enzym
henc
make
speci
human
make
produc
natur
antibodi
sometim
larg
amount
specif
sugar
antibodi
specif
monoreact
function
properti
like
antibodi
specif
b
blood
group
therapeut
strategi
limit
impact
xenoreact
antibodi
focus
immunoabsorpt
antibodi
inhibit
product
immunosuppress
drug
induct
toler
gener
pig
target
disrupt
transferas
variou
combin
approach
deplet
xenoreact
antibodi
passag
blood
xenogen
organ
immunoaffin
column
help
demonstr
antibodi
induc
much
activ
complement
xenogen
organ
graft
provid
prolong
graft
surviv
hand
regimen
immunosuppress
drug
yet
test
effect
inhibit
product
natur
antibodi
cyclosporin
leflunamid
agent
help
vari
extent
limit
product
elicit
antibodi
variou
strategi
devis
induc
toler
exampl
transferas
express
bone
marrow
cell
wouldb
recipi
appar
led
toler
rodent
howev
approach
induct
toler
test
date
includ
induct
mix
hematopoiet
chimer
yield
endur
state
toler
nonhuman
primat
rather
effect
way
deal
natur
antibodi
product
pig
target
disrupt
transferas
organ
pig
contain
littl
surviv
prolong
period
transplant
nonhuman
primat
howev
recipi
organ
pig
alway
treat
manipul
difficult
know
much
prolong
surviv
owe
absenc
xenogen
cell
also
recogn
nk
cell
recognit
lead
cytotox
vitro
mechan
give
rise
cytotox
thought
includ
follow
failur
major
histocompat
complex
mhc
class
xenogen
target
interact
killer
inhibitori
receptor
nk
cell
stimul
receptor
nk
cell
xenoreact
immunoglobulin
g
igg
bound
xenogen
cell
stimul
lectin
receptor
nk
cell
saccharid
xenogen
target
cell
activ
cytotox
receptor
extent
nk
cell
damag
organ
transplant
uncertain
immunodefici
anim
normal
nk
activ
accept
allograft
xenograft
howev
recent
studi
suggest
nk
cell
induc
vascular
injuri
period
time
especi
xenograft
nk
cell
might
also
promot
antigen
present
thu
elicit
immun
respons
direct
xenograft
respons
appear
main
limit
applic
xenotransplant
perhap
uncertainti
import
nk
cell
barrier
xenotransplant
therapeut
strategi
inhibit
cell
discuss
far
advanc
among
consider
transgen
express
human
leukocyt
antigen
hla
e
stimul
inhibitori
receptor
besid
compon
gener
view
element
innat
immun
system
phagocyt
neutrophil
macrophag
platelet
coagul
system
recogn
react
directli
xenograft
cours
element
also
recruit
innat
adapt
immun
respons
whether
cell
pathway
caus
greater
harm
direct
action
xenograft
effector
recruit
immun
reaction
test
howev
sinc
inhibit
innat
elicit
immun
larg
prevent
acut
destruct
xenograft
one
suspect
element
mainli
serv
accessori
capac
cell
clearli
recogn
destroy
xenograft
sinc
cellular
xenograft
surviv
nude
mice
wildtyp
mice
extent
mechan
cell
recogn
xenogen
cell
howev
matter
controversi
tcell
respons
xenogen
cell
appear
defect
evalu
vitro
cytokin
costimulatori
molecul
produc
xenogen
antigenpres
cell
apc
act
poorli
respond
cell
howev
xenogen
apc
present
foreign
mhc
antigen
cell
presum
use
altern
costimulatori
pathway
crossreact
properti
tcell
receptor
cell
may
also
respond
vitro
foreign
peptid
present
selfapc
although
natur
intens
tcell
respons
xenotransplant
still
complet
known
respons
like
least
intens
respons
allotransplant
owe
divers
set
antigen
peptid
amplifi
effect
humor
immun
inflamm
cellular
immun
respons
defect
immun
regul
xenogen
cell
tissu
elicit
power
divers
antibodi
respons
respons
like
tcelldepend
respons
control
extent
immunosuppress
therapi
elicit
immun
respons
seen
critic
barrier
transplant
xenogen
organ
yet
littl
known
specif
xenotransplant
lead
product
larg
amount
antibodi
consist
greater
fraction
igg
exhibit
higher
affin
natur
antibodi
howev
whether
antibodi
result
class
switch
recombin
affin
matur
b
cell
produc
natur
ig
activ
novel
clone
uncertain
product
antibodi
impact
graft
might
control
describ
elicit
antibodi
greater
import
probabl
tcelldepend
antibodi
specif
antigen
unfortun
littl
known
specif
antibodi
howev
antibodi
seen
anoth
import
barrier
success
transplant
xenogen
organ
impact
immun
respons
xenograft
xenotransplant
excit
nearli
everi
facet
innat
adapt
immun
impact
immun
respons
determin
much
intens
divers
respons
type
graft
implant
cell
tissu
organ
type
graft
determin
impact
immun
respons
determin
mean
graft
receiv
suppli
blood
vasculatur
graft
vulner
immunemedi
injuri
vascular
reject
particularli
hyperacut
acut
vascular
reject
caus
bind
antibodi
activ
complement
recipi
xenogen
blood
vessel
blood
vessel
origin
recipi
cell
tissu
xenograft
subject
type
problem
accommod
refer
acquir
resist
injuri
organ
xenograft
also
suscept
cellular
reject
b
outcom
free
tissu
cell
xenotranspl
cell
tissu
xenograft
deriv
blood
suppli
ingrowth
blood
vessel
recipi
sinc
blood
vessel
graft
construct
cell
recipi
antibodi
recipi
gener
bind
blood
vessel
henc
vascular
diseas
organ
graft
hyperacut
acut
vascular
reject
observ
free
tissu
cell
xenograft
mainli
subject
injuri
cell
abil
migrat
effect
blood
vessel
wall
caus
primari
nonfunct
cellular
reject
hyperacut
reject
refer
reject
organ
graft
within
hour
reperfus
arguabl
sever
violent
immunolog
reaction
reflect
loss
graft
function
destruct
organ
within
period
hour
hyperacut
reject
begin
within
minut
perfus
newli
transplant
organ
character
format
platelet
thrombi
bleed
graft
organ
transplant
dispar
speci
especi
suscept
hyperacut
reject
develop
hyperacut
reject
depend
absolut
activ
complement
organ
graft
combin
organ
recipi
speci
complement
activ
initi
directli
altern
pathway
owe
presum
speciesspecif
function
factor
h
type
hyperacut
reject
especi
sever
resist
therapi
perhap
attach
simultan
mani
avail
site
blood
vessel
wall
clinic
relev
combin
organ
recipi
eg
swine
organ
transplant
higher
primat
complement
activ
mainli
initi
classic
pathway
owe
bind
xenoreact
antibodi
involv
altern
pathway
secondari
set
kinet
extent
complement
activ
function
mainli
antibodyantigen
interact
hyperacut
reject
appear
reflect
loss
endotheli
cell
function
loss
trigger
termin
complement
complex
insert
endotheli
cell
membran
rate
complement
activ
appear
particularli
import
measur
slow
format
termin
complex
express
low
level
decayacceler
factor
andor
recipi
speci
blood
vessel
graft
may
prevent
diseas
hyperacut
reject
prevent
mean
hinder
activ
complement
transplant
pigtoprim
xenograft
mean
includ
deplet
xenoreact
antibodi
circul
recipi
elimin
gene
target
mean
antigen
recogn
inhibit
complement
reaction
express
product
transgen
complement
regulatori
protein
recipi
speci
hyperacut
reject
occur
prevent
xenograft
organ
suscept
acut
vascular
reject
acut
vascular
reject
emerg
period
day
week
character
endotheli
swell
focal
ischemia
intravascular
coagul
acut
vascular
reject
sometim
call
delay
xenograft
reject
acut
humor
reject
caus
destruct
xenograft
period
day
week
wide
seen
third
major
hurdl
clinic
applic
organ
xenotransplant
acut
vascular
reject
appear
caus
mainli
action
hour
day
antibodi
recipi
direct
graft
besid
antibodi
factor
includ
macrophag
platelet
nk
cell
implic
diseas
howev
transplant
physician
persuad
import
antibodi
type
reject
occur
allograft
often
refer
antibodymedi
reject
bind
antibodi
blood
vessel
graft
thought
caus
acut
vascular
reject
caus
hyperacut
reject
activ
endothelium
case
least
activ
endothelium
depend
activ
complement
particularli
insert
sublyt
amount
termin
complement
complex
endotheli
cell
termin
complement
complex
activ
interleukin
il
gene
lead
product
cytokin
condit
cytokin
determin
subsequ
fate
activ
versu
nonactiv
endothelium
henc
graft
endotheli
cell
activ
chang
postur
blood
vessel
anticoagul
procoagul
antiinflammatori
proinflammatori
sever
approach
pursu
effort
prevent
treat
acut
vascular
reject
extent
antibodi
trigger
acut
vascular
reject
induct
immunolog
toler
elimin
saccharid
transplant
might
prevent
initi
process
howev
neither
toler
induc
present
avail
mean
elimin
prevent
acut
vascular
reject
xenograft
case
antibodi
elicit
antigen
appear
incit
reject
perhap
toler
might
induc
broader
spectrum
antigen
transplant
hematopoiet
stem
cell
donor
speci
recipi
still
anoth
approach
prevent
acut
vascular
reject
xenotranspl
howev
may
involv
induct
accommod
accommod
acquir
resist
humor
injuri
acut
vascular
reject
organ
graft
accommod
first
observ
transplant
kidney
across
blood
group
b
barrier
transient
remov
antiblood
group
antibodi
recipi
transplant
follow
prolong
function
transplant
return
antibodi
circul
accommod
observ
rodent
model
xenotransplant
porcin
organ
transplant
baboon
organ
express
human
complement
regulatori
protein
xenoreact
antibodi
temporarili
deplet
circul
xenograft
recipi
accommod
may
exemplifi
broader
respons
cell
exhibit
revers
noxiou
pathway
develop
accommod
may
import
success
engraft
xenogen
organ
organ
contain
numer
antigen
could
evok
humor
immun
respons
origin
postul
accommod
may
reflect
one
three
chang
follow
organ
transplant
chang
natur
xenoreact
antibodi
chang
antigenimpair
antibodi
bind
induct
cellular
resist
humor
injuri
evid
would
present
point
acquir
resist
injuri
central
accommod
accommod
rodent
pigtoprim
xenograft
appear
associ
express
variou
antiapoptot
protein
heme
biolog
system
accommod
may
requir
akt
kinas
system
gene
signal
pathway
actual
bring
accommod
simpli
need
cell
surviv
accommod
per
se
still
uncertain
whether
frequenc
chronic
reject
would
occur
vascular
xenograft
uncertain
difficulti
overcom
acut
vascular
reject
clearli
ongo
product
impact
immun
respons
xenograft
antidonor
antibodi
might
expect
caus
chronic
reject
xenograft
complement
activ
endotheli
cell
smoothmuscl
cell
induc
prolifer
cell
develop
chronic
lesion
one
might
also
anticip
lesion
vascular
xenograft
whether
cellmedi
immun
would
caus
chronic
reject
xenograft
allograft
unknown
hand
extent
nonimmunolog
caus
chronic
reject
preserv
injuri
infect
contribut
chronic
reject
problem
might
less
organ
xenograft
organ
xenograft
subject
cellular
reject
less
like
observ
organ
allograft
reject
organ
xenograft
like
reject
organ
allograft
presum
target
foreign
major
histocompat
antigen
howev
unlik
allograft
practic
nonmhc
protein
xenograft
immunogen
discuss
sever
distinct
aspect
respons
said
cellular
immun
respons
xenograft
necessarili
limit
appar
subject
control
therapeut
agent
cellular
immun
respons
allograft
evid
suggest
respons
xenograft
may
especi
suscept
therapeut
aim
cell
organ
xenograft
plagu
coagul
thrombosi
thrombosi
occur
acut
vascular
reject
may
occur
independ
reject
owe
defect
control
thrombin
gener
hemostasi
xenogen
endothelium
two
potenti
mechan
latter
porcin
von
willebrand
factor
spontan
aggreg
human
platelet
porcin
thrombin
might
interact
ineffici
human
thrombomodulin
although
cell
tissu
xenograft
incit
humor
immun
respons
unlik
organ
xenograft
cell
tissu
xenograft
subject
devast
vascular
reject
cell
tissu
xenograft
suscept
vascular
reject
blood
vessel
graft
grow
recipi
thu
consist
cell
recipi
toler
consist
concept
cell
tissu
xenograft
appear
undisturb
high
level
antibodi
recipi
specif
graft
cell
hand
cell
tissu
xenograft
suscept
perhap
quit
suscept
primari
nonfunct
cellular
reject
fig
primari
nonfunct
cellular
reject
may
mediat
cell
howev
nk
cell
might
also
import
reason
discuss
barrier
xenotransplant
immunolog
respons
recipi
xenograft
pose
difficult
biolog
barrier
xenotransplant
potenti
transfer
infecti
organ
graft
recipi
may
imperil
health
commun
mani
microbi
organ
infect
one
relat
speci
influenza
sever
acut
respiratori
syndrom
sar
pass
dispar
speci
broadli
potenti
devast
consequ
principl
transfer
infect
graft
recipi
less
problem
xenotransplant
allotransplant
one
character
infecti
agent
present
anim
sourc
potenti
elimin
agent
breed
special
hous
condit
microbi
organ
present
sourc
xenograft
potenti
known
benefit
transplant
weigh
risk
infect
sourc
xenograft
speci
pig
close
contact
human
centuri
risk
zoonot
diseas
known
one
except
sanguin
view
transspeci
infect
xenotransplant
possibl
pig
might
endogen
retroviru
could
pass
human
caus
diseas
eventu
humantohuman
infect
endogen
retrovirus
broadli
repres
speci
inde
transmit
vertic
henc
easili
elimin
breed
porcin
endogen
retroviru
perv
present
variou
form
strain
pig
agent
perv
porcin
cell
line
activ
porcin
cell
infect
human
cell
cultur
howev
extens
survey
human
receiv
experiment
xenograft
variou
type
temporarili
expos
porcin
organ
blood
product
fail
provid
evid
perv
pass
pig
organ
tissu
human
cell
vivo
howev
analysi
chimer
pig
harbor
human
hematopoiet
cell
reveal
perv
could
pass
swine
human
cell
swine
human
cell
fuse
spontan
inde
cell
fusion
provid
potenti
mechan
retrovir
transfer
recombin
speci
fig
passag
perv
xenograft
could
provid
abund
sourc
organ
tissu
cell
transplant
xenograft
might
evad
recurr
viral
immunolog
diseas
day
human
cell
tissu
organ
might
actual
grown
anim
transfer
later
human
xenograft
provid
excel
model
elucid
mechan
vascular
diseas
accommod
test
efficaci
modifi
innat
adapt
immun
respons
human
cell
cell
fusion
would
miss
previou
survey
conclus
infect
occur
depend
quantit
semiquantit
polymeras
chain
reaction
pcr
assay
swinehuman
chimer
cell
fuse
gene
potenti
assay
pcr
reaction
lost
thu
question
perv
transfer
human
remain
answer
one
implic
xenotransplant
host
defens
pertain
control
intracellular
infect
cellmedi
immun
sinc
cellmedi
immun
depend
certain
extent
tcell
respons
less
mhcrestrict
recipi
might
control
virus
intracellular
organ
invad
graft
thu
factor
mhc
restrict
incompat
cytokin
cell
dhesion
molecul
impair
tcell
respons
xenogen
cell
discuss
might
greatest
impact
host
defens
present
limit
theoret
howev
conduct
experiment
transplant
notic
virus
cmv
may
engend
sever
complic
problem
recipi
xenograft
recipi
allograft
immunolog
xenotransplant
subject
medic
interest
applic
transplant
treatment
human
diseas
significantli
constrain
shortag
human
organ
overcom
immunolog
barrier
xenotransplant
would
sure
solv
problem
whether
xenotransplant
appli
purpos
extent
also
depend
advanc
made
technolog
one
might
imagin
clone
new
applic
stem
cell
could
effac
even
elimin
demand
xenotransplant
howev
interest
xenotransplant
like
persist
despit
failur
overcom
immunolog
barrier
advanc
altern
technolog
interest
stem
xenotransplant
experiment
model
thu
today
one
find
better
rigor
model
xenograft
test
efficaci
therapeut
complement
coagul
system
furthermor
xenograft
provid
power
model
elucid
mechan
complementmedi
injuri
pathophysiolog
endotheli
cell
activ
biolog
phenomenon
accommod
final
xenograft
begun
teach
unexpect
lesson
development
implic
cell
fusion
mechan
transfer
virus
speci
refer
